Selective Serotonin Reuptake Inhibitors: Overview of Regulatory Status and CSM Advice
British government (MHRA) summary of safety and efficacy data for SSRIs in major depressive disorder in children and adolescents.

No queries for www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&useSecondary=true&ssDocName=CON019494&ssTargetNodeId=221